Early prediction of the highest workload in incremental cardiopulmonary tests

Incremental tests are widely used in cardiopulmonary exercise testing, both in the clinical domain and in sport sciences. The highest workload (denoted Wpeak) reached in the test is key information for assessing the individual body response to the test and for analyzing possible cardiac failures and planning rehabilitation, and training sessions. Being physically very demanding, incremental tests can significantly increase the body stress on monitored individuals and may cause cardiopulmonary overload. This article presents a new approach to cardiopulmonary testing that addresses these drawbacks. During the test, our approach analyzes the individual body response to the exercise and predicts the Wpeak value that will be reached in the test and an evaluation of its accuracy. When the accuracy of the prediction becomes satisfactory, the test can be prematurely stopped, thus avoiding its entire execution. To predict Wpeak, we introduce a new index, the CardioPulmonary Efficiency Index (CPE), summarizing the cardiopulmonary response of the individual to the test. Our approach analyzes the CPE trend during the test, together with the characteristics of the individual, and predicts Wpeak. A K-nearest-neighbor-based classifier and an ANN-based classier are exploited for the prediction. The experimental evaluation showed that the Wpeak value can be predicted with a limited error from the first steps of the tes

The role of clinical pharmacology and pharmacogenetics in electroconvulsive therapy : from safety to efficacy

Electroconvulsive therapy (ECT) is the transcutaneous application of small electrical stimuli to the brain to produce generalized seizure for the treatment of selected psychiatric disorders, mostly treatment resistant depression, acute mania, and schizophrenic syndromes. Safety of ECT increases the efficacy of therapy and provides fulfillment of a series of required treatments resulting in longer treatment effect of ECT. During the last few decades, researchers have been attempting to improve the effectiveness of ECT, to learn how and why it works, and to understand its risks and adverse side effects. As a result, the safety and efficacy of ECT has been improved and its indications have been relatively defined to increase the efficiency of outcome of therapy. While there has been considerable improvement in safety features, further investigation have been done to promote both the safety and efficacy of the treatment. Such efforts could increase our knowledge on the biological mechanisms involved in effectiveness of ECT that might result in discovery of new treatments. In this dissertation, we investigate how preprocedural medications could improve the safety and efficacy of ECT and further investigated the potential role of pharmacogenetics in the efficacy of ECT and procedural side effects such as cognitive disorders.UBL - phd migration 201